相关实验视频

Updated: Jul 4, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

对核酸传感器的新见解 AIM2:针对癌症的向治疗的潜在益处

Jian-Zhou Cui¹, Zhi Huan Chew², Lina H K Lim³

¹Translational Immunology Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; NUS Immunology Program, Life Sciences Institute, National University of Singapore, Singapore; NUS-Cambridge Immunophenotyping Centre, Life Science Institute, National University of Singapore, Singapore.

Pharmacological research

|January 25, 2024

概括

AIM2炎症酶体感知各种核酸,影响细胞死亡和癌症. 调节这种免疫复合体显示出治疗癌症治疗的治疗前景.

科学领域:

这是天生的免疫力.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

AIM2炎症体是双链DNA (dsDNA) 的一个关键的先天免疫传感器.
它除了dSDNA之外还能识别多种不同的核酸,包括RNA和DNA-RNA杂交物.
激活AIM2导致炎症酶组装,处理 IL-1β和IL-18等促炎细胞因子.

研究的目的:

审查AIM2核酸传感能力的最新进展.
讨论AIM2在各种形式的细胞死亡中的作用 (烧死,亡,自).
探索AIM2在癌症中的双重作用 (抗瘤和亲瘤).

主要方法:

关于AIM2炎症组研究的文献综述.
对AIM2与不同核酸相互作用的研究分析.
检查将AIM2与癌症发展和进展联系在一起的证据.

主要成果:

AIM2识别的核酸范围比最初想象的更广泛.
激活AIM2可以触发不同的细胞死亡途径.
AIM2在癌症中表现出上下文依赖的作用,同时作为瘤抑制剂和促进剂.

结论:

了解AIM2在免疫和癌症中的多方面的作用至关重要.
准AIM2炎症酶组为癌症治疗提供了一个潜在的治疗策略.

关键词:

在AIM2炎症中,AIM2炎症细胞质DNA是细胞质DNA.DNA-RNA 杂交的混合物免疫治疗是一种免疫疗法.在PD-L1中.热灭菌的发生.

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...